CompletedPhase 3NCT02054156
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bonnie Ramsey
- Principal Investigator
- Bonnie Ramsey, MDSeattle Children's Center for Clinical and Translational Research, CF Therapeutics Development Network Clinical Coordinating Center
- Intervention
- azithromycin(drug)
- Enrollment
- 221 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2018
Study locations (30)
- CFF Affiliate Program Providence Medical Center, Anchorage, Alaska, United States
- CFF Care Center Arizona Health Science Center, Tucson, Arizona, United States
- CFF Care Center & Pediatric Program Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Childrens Hospital Los Angeles, Los Angeles, California, United States
- CFF Care Center & Pediatric Program Stanford University, Palo Alto, California, United States
- CFF Care Center & Pediatric Program Children's Hospital Colorado, Aurora, Colorado, United States
- CFF Care Center & Pediatric Program Yale University, New Haven, Connecticut, United States
- CFF Care Center & Pediatric Program Nemours Children's Clinic - Jacksonville, Jacksonville, Florida, United States
- CFF Care Center & Pediatric Program All Children's Hospital, St. Petersburg, Florida, United States
- CFF Care Center & Pediatric Program Emory University, Atlanta, Georgia, United States
- CFF Affiliate Program Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- CFF Care Center St. Luke's CF Clinic, Boise, Idaho, United States
- CFF Care Center & Pediatric Program Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- CFF Care Center & Pediatric Program Riley Hospital for Children, Indianapolis, Indiana, United States
- CFF Care Center & Pediatric Program University of Iowa, Iowa City, Iowa, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02054156 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.
- RECRUITINGPHASE1NCT07283770Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNCT07363304Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.Meyer Children's Hospital IRCCS